Literature DB >> 33409101

Association Between Marijuana Use and Cardiovascular Disease in US Adults.

Dhaval Jivanji1, Maverick Mangosing2, Sean P Mahoney2, Grettel Castro3, Juan Zevallos4, Juan Lozano5.   

Abstract

Introduction The prevalence of marijuana use has increased by about 16% since 2006, translating to approximately 200 million people worldwide. Being so widely used, long-term effects of marijuana use on cardiovascular health are largely unknown. Previous studies have had conflicting results, either showing marijuana use having a negative impact or no significant impact on cardiovascular health. This study aims to add evidence regarding the impact marijuana use has on the prevalence of cardiovascular disease. Methods This retrospective study was conducted using the Behavioral Risk Factor Surveillance System (BRFSS) database. Patients who completed the questionnaire and answered all questions in relation to marijuana use and the diagnosis of cardiovascular disease in 2017 were a part of this study. Subjects were excluded if they were children (<18 years old) or had missing data for marijuana use or cardiovascular disease. Age, gender, race/ethnicity, body mass index (BMI), income, exercise, tobacco use, alcohol use, and depression were all considered as potential confounders. Bivariate analysis was conducted to find an initial association between marijuana use and cardiovascular disease, which was followed by a multivariate regression analysis to adjust for confounders. Odds ratios and 95% confidence intervals were calculated.  Results A total of 56,742 subjects were included in the analysis. The unadjusted bivariate analysis showed a reduced prevalence of cardiovascular disease in individuals using marijuana (OR 0.65, 95%CI [0.50-0.84]). After adjustment with all additional variables, an adjusted model showed a similar odds ratio, but statistical significance of the association was lost (OR 0.74, 95%CI [0.54-1.01]). Discussion A systematic review by Ravi et al in 2018, which looked at marijuana use, cardiovascular risk factors, and clinical outcomes concluded that there was insufficient data to make conclusions regarding the effect of marijuana use and negative long-term cardiovascular effects. Our study lends support to the notion that marijuana use does not have an association with cardiovascular disease. A limitation in our study was that there was missing data from the BRFSS questionnaire due to participants not fully answering all questions concerning cardiovascular disease and marijuana use. This decreased our sample size from 67,974 to 56,742 subjects. The missing participants led to a decrease in the power of our odds ratio, which may have impacted statistical significance of our results.  Conclusion Although previous literature has shown that marijuana use has a negative impact on cardiovascular health, our study suggests that users and non-users of marijuana did not have an association with the prevalence of cardiovascular disease. Varying levels of support within the literature highlights the need for further research of this association.
Copyright © 2020, Jivanji et al.

Entities:  

Keywords:  cannabis; cardiovascular disease; marijuana; prevalence

Year:  2020        PMID: 33409101      PMCID: PMC7781563          DOI: 10.7759/cureus.11868

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  2 in total

1.  Consensus-based guidance for conducting and reporting multi-analyst studies.

Authors:  Balazs Aczel; Barnabas Szaszi; Gustav Nilsonne; Olmo R van den Akker; Casper J Albers; Marcel Alm van Assen; Jojanneke A Bastiaansen; Daniel Benjamin; Udo Boehm; Rotem Botvinik-Nezer; Laura F Bringmann; Niko A Busch; Emmanuel Caruyer; Andrea M Cataldo; Nelson Cowan; Andrew Delios; Noah Nn van Dongen; Chris Donkin; Johnny B van Doorn; Anna Dreber; Gilles Dutilh; Gary F Egan; Morton Ann Gernsbacher; Rink Hoekstra; Sabine Hoffmann; Felix Holzmeister; Juergen Huber; Magnus Johannesson; Kai J Jonas; Alexander T Kindel; Michael Kirchler; Yoram K Kunkels; D Stephen Lindsay; Jean-Francois Mangin; Dora Matzke; Marcus R Munafò; Ben R Newell; Brian A Nosek; Russell A Poldrack; Don van Ravenzwaaij; Jörg Rieskamp; Matthew J Salganik; Alexandra Sarafoglou; Tom Schonberg; Martin Schweinsberg; David Shanks; Raphael Silberzahn; Daniel J Simons; Barbara A Spellman; Samuel St-Jean; Jeffrey J Starns; Eric Luis Uhlmann; Jelte Wicherts; Eric-Jan Wagenmakers
Journal:  Elife       Date:  2021-11-09       Impact factor: 8.140

2.  Epidemiology, Burden, and Association of Substance Abuse Amongst Patients With Cardiovascular Disorders: National Cross-Sectional Survey Study.

Authors:  Nikhila Chelikam; Vandit Vyas; Lavanya Dondapati; Beshoy Iskander; Ghanshyam Patel; Siddhant Jain; Tanvi Singla; Ali Bombaywala; Daniel Zarrate; Neha Debnath; Nitesh K Jain; Appala Suman Peela; Urvish K Patel; Amit Sharma
Journal:  Cureus       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.